| | Real World Effectiveness of Benzydamine + Chlorhexidine on Sore Throat of COVID-19 Patients (Difflam-C® COVID-19) . . . |
Completed |
16 May 2023 |
| | A phase 2, randomized, double-blind, placebo controlled, dose-ranging trial to evaluate pharmacokinetics, pharmacodynamics, and safety of AT-752 in patients with Dengue infection . . . |
Ongoing |
09 Sep 2022 |
| | A Phase 3, Randomized, Double-Blind, Active-Controlled, Confirmatory Study to Compare the Immunogenicity, Efficacy, and Safety of KD-414 Vaccine and Vaxzevria Vaccine in Adults Aged 18 years and Older . . . |
Ongoing |
30 Nov -0001 |
| | Anti-Coronavirus Therapies to prevent progression of COVID19 (ACT), a randomized trial |
Ongoing |
30 Sep 2020 |
| | ASSOCIATION OF IN-PATIENT OUTCOMES AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITOR USE AMONG HOSPITALIZED HYPERTENSIVE PATIENTS WITH CORONAVIRUS DISEASE 2019 (COVID-19) IN A TERTIARY GOVERNMENT HOS . . . |
Completed |
30 Nov -0001 |
| | Bacteriological Profile and Antibiogram of Isolates from Wound Exudates of Breast Cancer and Phyllodes Tumor Patients in a Tertiary Hospital in the Philippines . . . |
Ongoing |
12 Apr 2023 |
| | Characteristics of musculoskeletal signs and symptoms during the recovery phase of moderate to severe COVID-19 patients at the Philippine General Hospital . . . |
Ongoing |
30 Nov -0001 |
| | EFFECTIVENESS AND SAFETY OF SOYBEAN 4% OINTMENT VERSUS CLOBETASOL PROPIONATE 0.05% OINTMENT IN MILD PLAQUE PSORIASIS (BSA <3%): A RANDOMIZED CLINICAL TRIAL . . . |
Ongoing |
22 Apr 2022 |
| | EFFECTIVENESS OF 100% TEA TREE OIL (Melaleuca alternifolia) VERSUS SALICYLIC ACID + LACTIC ACID SOLUTION IN THE TREATMENT OF COMMON WARTS: A RANDOMIZED CONTROL TRIAL . . . |
Pending |
23 Feb 2021 |
| | Effectiveness of Simplified Negative Wound Pressure Therapy in Wound Healing of Diabetic Foot Ulcers: A Randomized Control Study. . . . |
Pending |
30 Nov -0001 |
| | EFFICACY AND SAFETY OF MELALEUCA ALTERNIFOLIA (TEA TREE) 5% OIL VS. KETOCONAZOLE 2% CREAM IN THE MANAGEMENT OF MILD TO MODERATE FACIAL SEBORRHEIC DERMATITIS . . . |
Pending |
16 May 2022 |
| | EVALUATION OF Senna (Cassia) alata (Linn) Roxb. LEAF TOPICAL SOLUTION VERSUS KETOCONAZOLE 2% AS TREATMENT FOR SCALP SEBORRHEIC DERMATITIS . . . |
Ongoing |
30 Nov -0001 |
| | Intravenous Tocilizumab in the Treatment of Patients with Severe and Critical COVID-19-related Pneumonia . . . |
Ongoing |
05 Oct 2020 |
| | Knowledge and Attitudes of Obstetric and Gynecologic Patients at Philippine General Hospital on Covid-19 Information and Prevention Guidelines of the Department of Health . . . |
Completed |
21 Feb 2022 |
| | One Time Application of 80% Trichloroacetic Acid Peel versus 65% Trichloroacetic Acid Peel in the Clearance of Raised Seborrheic Keratosis in Filipino Patients: A Randomized Controlled Trial . . . |
Ongoing |
27 Jan 2023 |
| | Social media intervention in patients with psoriasis |
Ongoing |
06 Jul 2022 |
| | Text messages in patients with psoriasis |
Completed |
07 Jul 2022 |
| | The Effect in the Acid-base status, Electrolyte levels and Anion-gap following Initial Fluid Resuscitation in Children with Septic Shock with Normal saline, Lactated Ringers and Acetated Isotonic Elec . . . |
Ongoing |
30 Nov -0001 |
| | A Study Evaluating the Safety and Immunogenicity of Mixing Different COVID-19 Vaccines and Vaccine Platforms in Filipino Adults. . . . |
Ongoing |
31 Aug 2022 |
| | INNOVATE- Inovio INO-4800 Vaccine Trial for Efficacy |
Terminated |
22 Jun 2022 |
| | A 12-Month Open-Label Study to Evaluate the Safety and Tolerability of Pregabalin as Adjunctive Therapy in Pediatric Subjects 1 Month to 16 Years of Age with Partial Onset Seizures and Pediatric and A . . . |
Completed |
17 Jul 2019 |
| | A 12-month, phase III, randomized, double-masked, multicenter, active-controlled study to evaluate the efficacy and safety of two individualized regimens of 0.5 mg ranibizumab vs. verteporfin PDT in p . . . |
Completed |
25 Jan 2022 |
| | A 12-week phase 3, randomized, double-blind, placebo controlled study to evaluate the efficacy and safety of once monthly subcutaneous erenumab 70 mg in adult chronic migraine patients . . . |
Ongoing |
25 Jun 2021 |
| | A 12-week randomized, participant-and investigator-blinded, placebo-controlled, parallel group study to explore the efficacy, pharmacodynamics, safety, and pharmacokinetics of two doses of inhaled CSJ . . . |
Pending |
30 Nov -0001 |
| | A 12-week, multicenter, randomized, double-blind, parallel-arm, placebo-controlled study to assess the efficacy and safety of CSJ117, when added to existing asthma therapy in patients ≥18 years of a . . . |
Ongoing |
21 May 2021 |